The development of the new China campus marks a continuation of SAFC's "build and acquire" strategy, put in place to meet the increased demands for its medicinal chemistry and cGMP manufacturing services. The site complements Sigma-Aldrich's state-of-the- art Bangalore, India facility, which commenced production in October, 2006. Representing an investment of $12 million, the 139,000 sq. ft. India site supports customers with the manufacture of small-scale, key intermediates for medicinal chemistry.
About SAFC: SAFC is the custom manufacturing and services group within Sigma-Aldrich that focuses on high-purity inorganics for high technology applications, cell culture products and services for biopharmaceutical manufacturing, biochemical production and the manufacturing of complex, multi-step organic synthesis of APIs and key intermediates. SAFC has manufacturing facilities around the world dedicated to providing manufacturing services for companies requiring a reliable partner to produce their custom manufactured materials. SAFC has four focus areas -- SAFC Pharma, SAFC Supply Solutions, SAFC Biosciences, and SAFC Hitech -- and had annual sales of nearly $500 million in 2006. SAFC is one of the world's 10 largest fine chemical businesses. For more information about SAFC, visit http://www.safcglobal.com.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High
Technology company. Our biochemical and organic chemical products and kits
are used in scientific and genomic research, biotechnology, pharmaceutical
development, the diagnosis of disease and as key components in
pharmaceutical and other high technology manufacturing. We have customers
in life science companies, university and government institutions,
hospitals and in industry. Over one million scientists and technologists
Copyright©2007 PR Newswire.
All rights reserved